Filter by: Subject

Filter by: Subject

Results Per Page:

Alternative splicing (4)
SDG-03: Good health and well-being (3)
Biomarkers (2)
Colorectal cancer (CRC) (2)
Human papillomavirus (HPV) (2)
Neurogenesis (2)
Precision medicine (2)
Splice variants (2)
Therapeutic targets (2)
Aberrant splicing events (1)
Adenocarcinoma (1)
Alcohol consumption (1)
Alternative mRNA splicing (AS) (1)
Androgen receptor (AR) (1)
Angiogenesis (1)
Artificial intelligence (AI) (1)
AS events (1)
Axonogenesis (1)
Cancer growth and development (1)
Cancer therapy and control (1)
Carcinogenesis (1)
Castrate resistance prostate cancer (CRPC) (1)
Cell surface receptors (1)
Chemotherapy (1)
Drug resistance (1)
Esophageal squamous cell carcinoma (1)
Growth factor (1)
Gut–brain axis (1)
Head and neck squamous cell carcinoma (HNSCC) (1)
Hormone therapy (1)
Human immunodeficiency virus (HIV) (1)
Immunity (1)
Low- and middle-income countries (LMICs) (1)
Machine learning (1)
Metabolites (1)
Metastasis (1)
Methylation (1)
Microbiota (1)
MicroRNA (miRNA) (1)
MicroRNAs (miRNAs) (1)
Mutational burden (1)
Neoneurogenesis (1)
Nerves (1)
Neural stem cells (1)
Neurotransmitter (1)
Neurotransmitters (1)
Neurotrophin (1)
Next-generation sequencing (NGS) (1)
Non-coding RNA (ncRNA) (1)
Oesophageal cancer (1)
Oesophageal squamous cell carcinoma (OSCC) (1)
Personalized medicine (1)
Personalized oncology (1)
Physical activity (1)
Precision oncology (1)
PRMT inhibitors (1)
PRMT isoforms (1)
Prostate cancer (PCa) (1)
Prostate cancer disparities (1)
Protein arginine methyltransferase (PMRT) (1)
Protein arginine methyltransferases (1)
RAS pathway (1)
Reactive oxygen species (1)
Splicing disrupter drugs (1)
Splicing factor kinases (1)
Tissue remodeling (1)
Tumor mutational burden (1)
WNT signaling pathway (1)